Verily

Verily Life Sciences LLC, a subsidiary of Alphabet Inc., operates as a U.S.-based healthcare technology company founded in 2015. It specializes in improving health outcomes through advanced data-driven research and digital health solutions. Verily develops sophisticated software platforms, powerful analytics tools, and comprehensive clinical research systems designed to integrate and analyze vast amounts of biomedical and health data. The company's core mission revolves around making health information useful and actionable, driving innovation in precision health and life sciences. Its product suite includes offerings focused on precision medicine, health technology, and end-to-end platforms for managing health information.

With a significant operational footprint, Verily employs between 1,000 and 5,000 individuals across 6 locations. The company leverages deep scientific expertise and technological capabilities to address complex health challenges, from understanding disease progression to developing new interventions. Its focus extends to creating high-quality, equitable health opportunities throughout the lifecycle of health information. For insights into the people driving these innovations, you can Meet Verily's team. Verily's commitment to data privacy and protection is paramount in its handling of personal health information.

Financially, Verily reported a revenue of $285.7M. The company has a robust funding history, including substantial rounds from investors like Alphabet, Silver Lake, Temasek, and Ontario Teachers' Pension Plan, indicating strong backing for its ambitious projects. Its competitive landscape includes notable players in healthcare technology and life sciences such as iRhythm Technologies, Ginkgo Bioworks, and Johnson & Johnson Innovation. To delve deeper into its financial performance and metrics, explore Explore financial highlights. Verily's strategic investmentsView more...